RANDOMIZED COMPARATIVE STUDY OF DAILY DAPSONE AND DAILY ATOVAQUONE AGAINST PCP

Project Details

Description

This Phase II/III study is being conducted to determine the efficacy and safety of dapsone and atovaquone as PCP prophylactic agents for HIV infected patients who are at high risk for PCP and who are trimethoprim and/or sulfonamide intolerant.
StatusFinished
Effective start/end date1/10/9530/09/96

Funding

  • National Center for Research Resources

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.